Farritor wins inaugural NU faculty commercialization honor

Shane Farritor, co-founder and chief technology officer of Virtual Incision, is the inaugural winner of the University of Nebraska system’s Faculty IP Innovation and Commercialization Award. Virtual Incision, a member of Bio Nebraska, is working to commercialize miniature surgical robots for minimally invasive procedures.

Novartis Pluvicto™ approved by FDA

Novartis, a member of Bio Nebraska, announced that the FDA approved Pluvicto, a targeted radioligand therapy (RLT) for eligible patients with metastatic castration-resistant prostate cancer. Pluvicto is expected to be available to physicians and patients within weeks.

Member Spotlight: Precision Syringe

For our April Member Spotlight, we talked to Adrian Blake, CEO of Precision Syringe, a company set up to commercialize the Suh Precision Syringe, invented by a team from the University of Nebraska Medical Center and led by Dr. Donny Suh.

UMR Reports 2021 NIH Funding Impact on Nebraska

In Nebraska, the report finds that NIH awarded $136.9 million in grants and contracts during the 2021 fiscal year that directly supported 2,438 jobs and $346 million of economic activity.